138 related articles for article (PubMed ID: 37804290)
1. 1- or 3-Month DAPT in Patients With HBR With or Without Oral Anticoagulant Therapy After PCI.
Valgimigli M; Spirito A; Sartori S; Angiolillo DJ; Vranckx P; de la Torre Hernandez JM; Krucoff MW; Bangalore S; Bhatt DL; Campo G; Cao D; Chehab BM; Choi JW; Feng Y; Ge J; Hermiller J; Kunadian V; Lupo S; Makkar RR; Maksoud A; Neumann FJ; Picon H; Saito S; Sardella G; Thiele H; Toelg R; Varenne O; Vogel B; Zhou Y; Windecker S; Mehran R
JACC Cardiovasc Interv; 2023 Oct; 16(20):2498-2510. PubMed ID: 37804290
[TBL] [Abstract][Full Text] [Related]
2. 3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation.
Mehran R; Cao D; Angiolillo DJ; Bangalore S; Bhatt DL; Ge J; Hermiller J; Makkar RR; Neumann FJ; Saito S; Picon H; Toelg R; Maksoud A; Chehab BM; De la Torre Hernandez JM; Kunadian V; Sardella G; Thiele H; Varenne O; Vranckx P; Windecker S; Zhou Y; Krucoff MW; Ruster K; Wang J; Valgimigli M;
JACC Cardiovasc Interv; 2021 Sep; 14(17):1870-1883. PubMed ID: 34503737
[TBL] [Abstract][Full Text] [Related]
3. Duration of Dual Antiplatelet Therapy for Patients at High Bleeding Risk Undergoing PCI.
Valgimigli M; Cao D; Angiolillo DJ; Bangalore S; Bhatt DL; Ge J; Hermiller J; Makkar RR; Neumann FJ; Saito S; Picon H; Toelg R; Maksoud A; Chehab BM; Choi JW; Campo G; De la Torre Hernandez JM; Kunadian V; Sardella G; Thiele H; Varenne O; Vranckx P; Windecker S; Zhou Y; Krucoff MW; Ruster K; Zheng Y; Mehran R;
J Am Coll Cardiol; 2021 Nov; 78(21):2060-2072. PubMed ID: 34794687
[TBL] [Abstract][Full Text] [Related]
4. Clopidogrel Monotherapy After 1-Month Dual Antiplatelet Therapy in Patients With Diabetes Undergoing Percutaneous Coronary Intervention.
Yamamoto K; Watanabe H; Morimoto T; Obayashi Y; Natsuaki M; Yamaji K; Domei T; Ogita M; Ohya M; Tatsushima S; Suzuki H; Tada T; Ishii M; Nikaido A; Watanabe N; Fujii S; Mori H; Nishikura T; Suematsu N; Hayashi F; Komiyama K; Shigematsu T; Isawa T; Suwa S; Ando K; Kimura T;
JACC Cardiovasc Interv; 2023 Jan; 16(1):19-31. PubMed ID: 36599584
[TBL] [Abstract][Full Text] [Related]
5. One- versus three-month dual antiplatelet therapy in high bleeding risk patients undergoing percutaneous coronary intervention for non-ST-segment elevation acute coronary syndromes.
Cao D; Vranckx P; Valgimigli M; Sartori S; Angiolillo DJ; Bangalore S; Bhatt DL; Feng Y; Ge J; Hermiller J; Makkar RR; Neumann FJ; Saito S; Picon H; Toelg R; Maksoud A; Chehab BM; Choi JW; Campo G; De la Torre Hernandez JM; Krucoff MW; Kunadian V; Sardella G; Spirito A; Thiele H; Varenne O; Vogel B; Zhou Y; Windecker S; Mehran R
EuroIntervention; 2024 May; 20(10):e630-e642. PubMed ID: 38776146
[TBL] [Abstract][Full Text] [Related]
6. Design and rationale of the XIENCE short DAPT clinical program: An assessment of the safety of 3-month and 1-month DAPT in patients at high bleeding risk undergoing PCI with an everolimus-eluting stent.
Valgimigli M; Cao D; Makkar RR; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Ge J; Neumann FJ; Hermiller J; Picon H; Toelg R; Maksoud A; Chehab BM; Wang LJ; Wang J; Mehran R
Am Heart J; 2021 Jan; 231():147-156. PubMed ID: 33031789
[TBL] [Abstract][Full Text] [Related]
7. 1- Versus 3-Month DAPT in Older Patients at a High Bleeding Risk Undergoing PCI: Insights from the XIENCE Short DAPT Global Program.
Sardella G; Spirito A; Sartori S; Angiolillo DJ; Vranckx P; Hernandez JMT; Krucoff MW; Bangalore S; Bhatt DL; Campo G; Cao D; Chehab BM; Choi JW; Feng Y; Ge J; Godfrey K; Hermiller J; Kunadian V; Makkar RR; Maksoud A; Neumann FJ; Picon H; Saito S; Thiele H; Toelg R; Varenne O; Vogel B; Zhou Y; Valgimigli M; Windecker S; Mehran R
Am J Cardiol; 2024 Mar; 214():94-104. PubMed ID: 38185438
[TBL] [Abstract][Full Text] [Related]
8. One-Month Dual Antiplatelet Therapy in Patients With Chronic and Acute Coronary Syndromes Treated With Bioresorbable Polymer Everolimus-Eluting Stents.
Musto C; Paolucci L; Pivato CA; Testa L; Pacchioni A; Briguori C; Esposito G; Piccolo R; Lucisano L; De Luca L; Conrotto F; Sanz-Sanchez J; Cesario V; De Felice F; Latini AC; Regazzoli D; Sardella G; Indolfi C; Reimers B; Condorelli G; Stefanini G
Am J Cardiol; 2023 Nov; 207():170-178. PubMed ID: 37741107
[TBL] [Abstract][Full Text] [Related]
9. Duration of antiplatelet therapy after complex percutaneous coronary intervention in patients at high bleeding risk: a MASTER DAPT trial sub-analysis.
Valgimigli M; Smits PC; Frigoli E; Bongiovanni D; Tijssen J; Hovasse T; Mafragi A; Ruifrok WT; Karageorgiev D; Aminian A; Garducci S; Merkely B; Routledge H; Ando K; Diaz Fernandez JF; Cuisset T; Nesa Malik FT; Halabi M; Belle L; Din J; Beygui F; Abhyankar A; Reczuch K; Pedrazzini G; Heg D; Vranckx P;
Eur Heart J; 2022 Sep; 43(33):3100-3114. PubMed ID: 35580836
[TBL] [Abstract][Full Text] [Related]
10. Two-year results from Onyx ONE clear in patients with high bleeding risk on one-month DAPT with and without intracoronary imaging.
Toth GG; Kandzari DE; Kirtane AJ; Windecker S; Latib A; Kedhi E; Mehran R; Price MJ; Choi JW; Caputo R; Troquay R; Diderholm E; Singh S; Brar SS; Loussararian A; Chetcuti S; Tulli M; Stone GW; Lung TH; Mylotte D
Cardiovasc Revasc Med; 2024 Jan; 58():60-67. PubMed ID: 37550123
[TBL] [Abstract][Full Text] [Related]
11. Dual antiplatelet therapy duration after percutaneous coronary intervention using drug eluting stents in high bleeding risk patients: A systematic review and meta-analysis.
Garg A; Rout A; Farhan S; Waxman S; Giustino G; Tayal R; Abbott JD; Huber K; Angiolillo DJ; Rao SV
Am Heart J; 2022 Aug; 250():1-10. PubMed ID: 35436504
[TBL] [Abstract][Full Text] [Related]
12. Duration of dual antiplatelet therapy after myocardial infarction: Insights from a pooled database of the SMART-DATE and DAPT-STEMI trials.
Kedhi E; Delewi R; Fabris E; De Luca G; Hermanides RS; van den Ent M; Buszman P; Zijlstra F; Song YB; Gwon HC; Hahn JY
Atherosclerosis; 2020 Dec; 315():55-61. PubMed ID: 33227548
[TBL] [Abstract][Full Text] [Related]
13. 6-Month Versus 12-Month Dual-Antiplatelet Therapy Following Long Everolimus-Eluting Stent Implantation: The IVUS-XPL Randomized Clinical Trial.
Hong SJ; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Her AY; Kim YH; Jang Y; Hong MK;
JACC Cardiovasc Interv; 2016 Jul; 9(14):1438-46. PubMed ID: 27212028
[TBL] [Abstract][Full Text] [Related]
14. Clopidogrel Monotherapy After 1-Month DAPT in Patients With High Bleeding Risk or Complex PCI.
Yamamoto K; Watanabe H; Morimoto T; Obayashi Y; Natsuaki M; Domei T; Yamaji K; Suwa S; Isawa T; Watanabe H; Yoshida R; Sakamoto H; Akao M; Hata Y; Morishima I; Tokuyama H; Yagi M; Suzuki H; Wakabayashi K; Suematsu N; Inada T; Tamura T; Okayama H; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Morino Y; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
JACC Asia; 2023 Feb; 3(1):31-46. PubMed ID: 36873770
[TBL] [Abstract][Full Text] [Related]
15. Details on the effect of very short dual antiplatelet therapy after drug-eluting stent implantation in patients with high bleeding risk: insight from the STOPDAPT-2 trial.
Watanabe H; Domei T; Morimoto T; Natsuaki M; Shiomi H; Toyota T; Ohya M; Suwa S; Takagi K; Nanasato M; Hata Y; Yagi M; Suematsu N; Yokomatsu T; Takamisawa I; Doi M; Noda T; Okayama H; Seino Y; Tada T; Sakamoto H; Hibi K; Abe M; Kawai K; Nakao K; Ando K; Tanabe K; Ikari Y; Hanaoka KI; Morino Y; Kozuma K; Kadota K; Furukawa Y; Nakagawa Y; Kimura T;
Cardiovasc Interv Ther; 2021 Jan; 36(1):91-103. PubMed ID: 32086787
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Safety and Efficacy of Durable Polymer Cobalt-Chromium Everolimus-Eluting Stents in Patients at High Bleeding Risk: A Patient-Level Stratified Analysis From Four Postapproval Studies.
Sorrentino S; Claessen BE; Chandiramani R; Guedeney P; Vogel B; Baber U; Rau V; Wang J; Krucoff M; Kozuma K; Ge J; Seth A; Makkar R; Liu Y; Bangalore S; Bhatt DL; Angiolillo DJ; Saito S; Neumann FJ; Hermiller J; Valgimigli M; Mehran R
Circulation; 2020 Mar; 141(11):891-901. PubMed ID: 31992063
[TBL] [Abstract][Full Text] [Related]
17. Comparison of one-month versus twelve-month dual antiplatelet therapy after implantation of drug-eluting stents guided by either intravascular ultrasound or angiography in patients with acute coronary syndrome: rationale and design of prospective, multicenter, randomized, controlled IVUS-ACS and ULTIMATE-DAPT trial.
Ge Z; Gao XF; Kan J; Kong XQ; Zuo GF; Ye F; Tian NL; Lin S; Liu ZZ; Shao YB; He YQ; Wen SY; Yang Q; Xia Y; Wang ZZ; Xiao PX; Li F; Zeng HS; Yang S; Wang Y; Tao L; Gao DS; Qu H; Qian XS; Han YL; Chen F; Zhang JJ; Chen SL
Am Heart J; 2021 Jun; 236():49-58. PubMed ID: 33621541
[TBL] [Abstract][Full Text] [Related]
18. Impact of age on the comparison between short-term vs 12-month dual antiplatelet therapy in patients with acute coronary syndrome treated with the COMBO dual therapy stent: 2-Year follow-up results of the REDUCE trial.
Kedhi E; Verdoia M; Suryapranata H; Damen S; Camaro C; Benit E; Barbieri L; Rasoul S; Liew HB; Polad J; Ahmad WA; Zambahari R; Lalmand J; van der Schaaf RJ; Koh TH; Timmermans P; Dilling-Boer D; Veenstra LF; Van' T Hof AW; Lee SW; Roolvink V; Ligtenberg E; Postma S; Kolkman EJ; Brouwer MA; Dudek D; De Luca G
Atherosclerosis; 2021 Mar; 321():39-44. PubMed ID: 33639478
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes in patients with acute coronary syndromes related to prolonging dual antiplatelet therapy more than 12 months after coronary stenting.
Wimmer NJ; Dufour AB; Cho K; Gagnon DR; Quach L; Ly S; Do JM; Ostrowski S; Michael Gaziano J; Faxon DP; Kinlay S
Catheter Cardiovasc Interv; 2017 Jun; 89(7):1176-1184. PubMed ID: 27860195
[TBL] [Abstract][Full Text] [Related]
20. Performance of HAS-BLED, ORBIT, PRECISE-DAPT, and PARIS risk score for predicting long-term bleeding events in patients taking an oral anticoagulant undergoing percutaneous coronary intervention.
Yoshida R; Ishii H; Morishima I; Tanaka A; Morita Y; Takagi K; Yoshioka N; Hirayama K; Iwakawa N; Tashiro H; Kojima H; Mitsuda T; Hitora Y; Furusawa K; Tsuboi H; Murohara T
J Cardiol; 2019 Jun; 73(6):479-487. PubMed ID: 30598387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
